Immunic (NASDAQ:IMUX) Raised to Hold at StockNews.com
StockNews.com upgraded shares of Immunic (NASDAQ:IMUX – Free Report) from a sell rating to a hold rating in a research report sent to investors on Wednesday. IMUX has been the subject of a number of other research reports. HC Wainwright restated a “buy” rating and set a $10.00 target price on shares of Immunic in […]
StockNews.com upgraded shares of Immunic (NASDAQ:IMUX – Free Report) from a sell rating to a hold rating in a research report sent to investors on Wednesday. IMUX has been the subject of a number of other research reports. HC Wainwright restated a “buy” rating and set a $10.00 target price on shares of Immunic in […]
